Some consumers in New York may be paying a higher co-payment for a prescription drug than the actual price of that medication, which prompted a state agency in New York to issue guidance this week aiming to prevent the practice.

The state Department of Financial Services said that so-called gag clauses, which prevent pharmacists from providing pricing information to insured consumers, have compounded the problem.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]